A phase I study of interleukin-2 in chil
โ
Sherif Nasr; John McKolanis; Ray Pais; Harry Findley; Robert Hnath; Kathy Waldre
๐
Article
๐
1989
๐
John Wiley and Sons
๐
English
โ 600 KB
The authors performed a Phase I study to assess the toxicity and hematologic effect of recombinant human interleukin-2 (rIL-2) in seven children with advanced malignancies. The rIL-2 was given as a bolus injection of 1 or 3 X lo6 U/m2/dose three times a week (Monday, Wednesday, and Friday) for 3 wee